Search Prime Grants

W81XWH2210123

Project Grant

Overview

Grant Description
Toward functional precision oncology to predict, prevent, and treat early metastatic recurrence of triple-negative breast cancer.
Awardee
University Of Utah
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding Agency
U.S. Army Medical Research Acquisition Activity (USAMRAA) [DoD - USA - MEDCOM - MRDC]
Funding Agency
Medical Command (MEDCOM) [DoD - USA]
Place of Performance
Salt Lake City, Utah 841129049 United States
Geographic Scope
Single Zip Code
Related Opportunity
0011720367
University Of Utah was awarded Precision Oncology for TNBC Metastatic Recurrence Project Grant W81XWH2210123 worth $6,079,790 from Medical Command in July 2022 with work to be completed primarily in Salt Lake City Utah United States. The grant has a duration of 4 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 5/10/22

Period of Performance
7/1/22
Start Date
6/30/26
End Date
79.0% Complete

Funding Split
$6.1M
Federal Obligation
$0.0
Non-Federal Obligation
$6.1M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to W81XWH2210123

Additional Detail

Award ID FAIN
W81XWH2210123
SAI Number
None
Award ID URI
None
Awardee Classifications
Public/State Controlled Institution Of Higher Education
State Government
Awarding Office
W81XWH W4PZ USA MED RSCH ACQUIS ACT
Funding Office
W91ZSQ W03J HQ CO USA MED DEV MAT CM
Awardee UEI
LL8GLEVH6MG3
Awardee CAGE
3T624
Performance District
02
Senators
Mike Lee
Mitt Romney
Representative
Chris Stewart
Modified: 5/10/22